Cargando…
Serum NGAL and FGF23 may have certain value in early diagnosis of CIN
Aims: This study aimed to assess whether neutrophil gelatinase-associated lipocalin (NGAL) and fibroblast growth factor 23 (FGF23) could be reliable biomarkers for early diagnosis of contrast-induced nephropathy (CIN). Methods: 202 patients who underwent percutaneous coronary intervention (PCI) were...
Autores principales: | Li, Huihui, Yu, Zaixin, Gan, Lu, Peng, Ling, Zhou, Qiaoling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171456/ https://www.ncbi.nlm.nih.gov/pubmed/30278796 http://dx.doi.org/10.1080/0886022X.2018.1487860 |
Ejemplares similares
-
Evaluation of a Diagnostic Test of Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Urine KIM-1 in Contrast-Induced Nephropathy (CIN)
por: Liao, Baoxia, et al.
Publicado: (2019) -
Prediction Value of Serum NGAL in the Diagnosis and Prognosis of Experimental Acute and Chronic Kidney Injuries
por: Wang, Weida, et al.
Publicado: (2020) -
Diagnosis of TIO: Is Serum FGF23 Measurement always the Answer?
por: Ramakrishnan, Anantharaman, et al.
Publicado: (2020) -
Does NGAL reduce costs? A cost analysis of urine NGAL (uNGAL) & serum creatinine (sCr) for acute kidney injury (AKI) diagnosis
por: Parikh, Amay, et al.
Publicado: (2017) -
Correction: Does NGAL reduce costs? A cost analysis of urine NGAL (uNGAL) & serum creatinine (sCr) for acute kidney injury (AKI) diagnosis
por: Parikh, Amay, et al.
Publicado: (2017)